Browsing by Author "Hidalgo, Manuel"

Sort by: Order: Results:

  • Hidalgo, Manuel; Cascinu, Stefano; Kleeff, Jörg; Labianca, Roberto; Löhr, J. Matthias; Neoptolemos, John; Real, Francisco X.; Van Laethem, Jean-Luc; Heinemann, Volker (Elsevier, 2015)
    Pancreatic ductal adenocarcinoma (PDAC), which accounts for more than 90% of all pancreatic tumours, is a devastating malignancy with an extremely poor prognosis, as shown by a 1-year survival rate of around 18% for all ...
  • Hidalgo, Manuel; Martinez, Alejandro; Carrato, Alfredo (Springer, 2017)
    The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management ...
  • Heil, Florian; Babitzki, Galina; Julien-Laferriere, Alice; Ooi, Chia-Huey; Hidalgo, Manuel; Massard, Christophe; Martinez-García, Maria; Le Tourneau, Christophe; Kockx, Mark; Gerber, Peter; Rossomanno, Simona; Krieter, Oliver; Lahr, Angelika; Wild, Norbert; Vega Harring, Suzana; Lechner, Katharina (Elsevier, 2021)
    Vanucizumab is a novel bispecific antibody inhibiting vascular endothelial growth factor (VEGF-A) and angiopoietin-2 (Ang-2) that demonstrated safety and anti-tumor activity in part I of a phase I study of 42 patients with ...

Search DSpace


My Account

In collaboration with Compliant to Partaking